Daiichi Sankyo Goes After Generics In Japan, Forms New Company With Ranbaxy

MUMBAI - As Teva and Mylan drill deeper into the steadily unfolding Japanese generic drugs market, Daiichi Sankyo - the third largest Japanese drug maker - does not want to be left behind